3D Systems Partners With National Institutes of Health (NIH) to Advance Medical Innovations Through 3D Printing
January 15 2015 - 4:45PM
- 3DS will play major role during 2015 Science in 3D
Festival
- Delivers expert healthcare-focused talks and exhibits on 3D
printing, 3D visualization and 3D simulation
- Showcases state-of-the-art 3D healthcare technology including
personalized surgery
3D Systems (NYSE:DDD) announced its role as a key partner in the
2015 Science in 3D Festival organized by the National Institute of
Allergy and Infectious Diseases (NIAID), part of the National
Institutes of Health (NIH). The event will be held on January
20-21, 2015, at the NIAID Fishers Lane Conference Center in
Rockville, Maryland. 3D Systems will feature prominently in
exhibits and lectures over the two day meeting. The festival will
explore all aspects of 3D modeling, 3D printing, surgical
simulation and visualization technologies through experts from
government, academia and the private sector. The event will also be
available via NIH VideoCast.
"As the leading American 3D printing company, 3DS is committed
to working with the federal government to enhance the delivery of
U.S. healthcare and drive innovation for novel therapies while
reducing overall healthcare costs," said Kevin McAlea, Executive
Vice President and Chief Operating Officer, Healthcare, 3DS. "This
event offers an important opportunity for us to explore common
R&D interests and capabilities across multiple
technologies—from 3D medical modeling, training and simulation to
3D printing of personalized medical instruments, implants and
surgical guides."
In 2014, the NIH 3D Print Exchange was launched to provide an
open and interactive website for sharing biomedical 3D print files,
modeling tutorials, and educational material. The Science in 3D
Festival builds upon this work to expand the use of 3D technology
to advance research and medical innovation.
3DS' healthcare portfolio continues to grow significantly, both
organically and through targeted acquisitions. From revolutionizing
the hearing aid industry with custom-fit 3D printed ear shells and
scalable, 3D manufacturing of millions of one-of-a-kind dental
aligners to working with physicians on tens of thousands of
personalized surgical procedures and facilitating virtual reality
surgical simulation, 3DS continues to lead the way in enhancing
healthcare worldwide.
3DS healthcare executives will be presenting several sessions
throughout the two-day event as follows:
- 3D Printing – Reshaping Healthcare in the 21st
Century, Andy Christensen, Vice President, Personalized
Surgery & Medical Devices, 3DS – January 20, 1:00 – 1:30 p.m.
EST
- 3D Scanning and 3D Printing: Using the Body to Design
for the Body, Scott Summit, Senior Director, Functional
Design, 3DS – January 20, 1:45 – 2:00 p.m. EST
- A Dress Rehearsal for Surgery, Ran Bronstein,
Vice President, Chief Research and Operation Officer for Simbionix
Products, 3DS – January 21, 10:00 – 10:15 a.m. EST
3DS will also showcase its extensive portfolio of healthcare
solutions that extend from the training room to the operating room.
3DS' end-to-end platform includes 3D simulation, training, virtual
surgical planning, guiding and delivery of 3D printed procedures
with many different types of patient specific medical devices.
Around the globe on a daily basis, surgeons use the company's
Virtual Surgical Planning (VSP®) services and patient-specific
anatomical models for guiding complex reconstructive surgeries
involving the face, orthopedic areas like the hip and knee, and
even organs such as the kidney and heart.
NIH VideoCast
This event will be available via online broadcast at the links
below.
Day 1 -
http://videocast.nih.gov/summary.asp?live=15415&bhcp=1
Day 2 -
http://videocast.nih.gov/summary.asp?live=15417&bhcp=1
Learn more about 3DS' commitment to manufacturing the future
today at www.3dsystems.com.
About 3D Systems
3D Systems is pioneering 3D printing for everyone. 3DS provides
the most advanced and comprehensive 3D design-to-manufacturing
solutions including 3D printers, print materials and cloud sourced
custom parts. Its powerful digital thread empowers professionals
and consumers everywhere to bring their ideas to life in material
choices including plastics, metals, ceramics and edibles. 3DS'
leading healthcare solutions include end-to-end simulation,
training and integrated 3D planning and printing for personalized
surgery and patient specific medical and dental devices. Its
democratized 3D design and inspection products embody the latest
perceptual, capture and touch technology. Its products and services
replace and complement traditional methods with improved results
and reduced time to outcomes. These solutions are used to rapidly
design, create, communicate, plan, guide, prototype or produce
functional parts, devices and assemblies, empowering customers to
manufacture the future.
Leadership Through Innovation and
Technology
- 3DS invented 3D printing with its Stereolithography (SLA)
printer and was the first to commercialize it in 1989.
- 3DS invented Selective Laser Sintering (SLS) printing and was
the first to commercialize it in 1992.
- 3DS invented the ColorJet Printing (CJP) class of 3D printers
and was the first to commercialize 3D powder-based systems in
1994.
- 3DS invented MultiJet Printing (MJP) printers and was the first
to commercialize it in 1996.
- 3DS Medical Modeling pioneered virtual surgical planning (VSP)
and its services are world-leading, helping many thousands of
patients on an annual basis.
Today its comprehensive range of 3D printers is the industry's
benchmark for production-grade manufacturing in aerospace,
automotive, patient specific medical device and a variety of
consumer, electronic and fashion accessories.
More information on the company is available at
www.3dsystems.com.
CONTACT: Investor Contact: Stacey Witten
Email: Stacey.Witten@3dsystems.com
Media Contact: Wendy Pinckney
Email: Press@3dsystems.com
3D Systems (NYSE:DDD)
Historical Stock Chart
From Mar 2024 to Apr 2024
3D Systems (NYSE:DDD)
Historical Stock Chart
From Apr 2023 to Apr 2024